Ying-Jun Chang1 article listing Ying-Jun Chang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial Nature Communications